Charles Mtabho

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis

R.E. Aarnoutse, Gibson Kibiki, Klaus Reither et al. · Antimicrobial Agents and Chemotherapy · 2017 · 93 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

Alma Tostmann, Charles Mtabho, Hadija Semvua et al. · Antimicrobial Agents and Chemotherapy · 2013 · 67 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy

Mohamed I. M. Ahmed, Nyanda Elias Ntinginya, Gibson Kibiki et al. · Frontiers in Immunology · 2018 · 59 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Childhood Tuberculosis in the Kilimanjaro region: lessons from and for the TB Programme

Charles Mtabho, Constantine F. Irongo, Martin J. Boeree et al. · Tropical Medicine & International Health · 2010 · 38 citations · Full text

Public Health, Child Health, Infectious Diseases +17

Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients

Charles Mtabho, Hadija Semvua, Jossy van den Boogaard et al. · Journal of Antimicrobial Chemotherapy · 2019 · 34 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14